JANX Janux Therapeutics, Inc.: Prakiraan rega marang bathi

JANX (Janux Therapeutics) - tandha merek perusahaan

Janux Therapeutics (JANX) develops targeted immune therapies against solid tumors, utilizing a diversified pipeline to mitigate risks. The company's forward P/E ratio history helps assess the asset's value, where the 0.00 metric determines the parameter status. Revenues are based on partnerships and the sale of lung cancer therapies. The environmental profile is limited to compliance with biohazardous waste disposal regulations.

januxrx.com - Pangali mangsa ngarep rega marang bathi JANX (periode 04.07.2022 - 17.11.2026)

Rincian metrik lan analitis perusahaan januxrx.com (JANX)

Analisis fundamental perusahaan:Janux Therapeutics Inc JANX
Produk mawa merek Janux Therapeutics

The metric is based on the sensitivity of market value to projected future cash flows. This indicator reflects collective market expectations regarding long-term returns, filtering out short-term volatility. For Janux Therapeutics (JANX), the calculation confirms a high premium for its status as a potential leader in oncology. The issuer's impeccable scientific reputation directly inflates profit expectations. By analyzing the forward P/E multiple for Janux Therapeutics (JANX), an investor determines the balance between drawdown risk and capitalization potential.

Analisis perusahaan pesaing

Pangali Forward P/E IBRX|Immunocore Holdings plc (IMCR) - Pangali forward rega marang bathi|Arcus Biosciences Inc - Prakiraan rega marang bathi|Zymeworks (ZYME) - Rasio prakiraan rega marang bathi|TNGX: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi IOVA (Iovance Biotherapeutics, Inc.)|IMTX: Pangali Forward P/E|XNCR - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep compasstherapeutics.com|Prakiraan rega marang bathi replimune.com (REPL)|Rega marang bathi mangsa ngarep Lyell (LYEL)|Prakiraan rega marang bathi Innate Pharma, S.A. IPHA|Pyxis Oncology Inc. - Prakiraan rega marang bathi|Pangali Forward P/E Compugen Ltd. CGEN|IOBT - Rega marang bathi mangsa ngarep|STRO (sutrobio.com) - Rasio rega marang bathi mangsa ngarep|MiNK Therapeutics, Inc (INKT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Werewolf Therapeutics (HOWL)|Prakiraan rega marang bathi IMMX|ALXO - Pangali forward rega marang bathi|Pangali Forward P/E CUE|Rasio kapitalisasi marang bathi mangsa ngarep PDSB|Pangali Forward P/E SONN (Sonnet BioTherapeutics)|Pangali mangsa ngarep rega marang bathi MAIA|liminatuspharma.com - Pangali Forward P/E|Rasio prakiraan rega marang bathi LAVA Therapeutics|NextCure, Inc. (NXTC) - Rega marang bathi mangsa ngarep|Leap Therapeutics Inc - Pangali mangsa ngarep rega marang bathi|INTS (Intensity Tx) - Pangali Forward P/E|Pangali Forward P/E senseibio.com|Rega marang bathi mangsa ngarep Theriva Biologics (TOVX)|GRTS: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E KA (kinetabio.com)|neximmune.com (NEXI) - Rasio prakiraan rega marang bathi|TSBX: Prakiraan rega marang bathi|VCNX: Rega marang bathi mangsa ngarep|HARP: Pangali Forward P/E